|
|
||||||||
Inorganic Carcinogenesis, Laboratory of Comparative Carcinogenesis, National Cancer Institute at NIEHS, Research Triangle Park, North Carolina 27709
1To whom requests for reprints should be addressed at Inorganic Carcinogenesis, Laboratory of Comparative Carcinogenesis, National Cancer Institute at NIEHS, Research Triangle Park, NC 27709. E-mail: Liu6{at}niehs.nih.gov
Ethanol-induced hepatic apoptosis has been widely recognized in both experimental and clinical alcoholic diseases. Several molecular pathways have been shown to be involved in alcohol-induced liver apoptosis and necrosis (1). These include ethanol-induced oxidative stress and cytokine production, such as TNF-
(12), and the Fas- and cytochrome cmediated caspase-3 activation pathway (3). Clearly, these pathways play integrated roles in alcoholic diseases.
The manuscript by Lambert et al. (4) is a logical extension of their recent work showing that the Fas-mediated signaling pathway plays a central role in acute ethanol-induced liver apoptosis (3) and has been selected for a Best Paper Award in the Clinical/Preclinical/Translational Category for 2003. In this paper, the authors demonstrate the protection of zinc against ethanol-induced liver apoptosis, as evidenced by Terminal Deoxynucleotidyl Transferase Nick-End Labeling (TUNEL) assay and electron microscopy. The ethanol-induced increases in caspase-3 and caspase-8 activities are also suppressed by zinc pretreatment. The immunohistochemical staining of Fas ligand (FasL) protein expression provides further evidence that zinc suppressed ethanol-induced expression of FasL. Thus, one important inhibitory mechanism of zinc action in acute ethanol-induced liver apoptosis is the abrogation of Fas/FasL-mediated caspase-8 activation and the subsequent caspase-3 activation, possibly through downregulation of FasL signaling pathways in hepatocytes.
Another important observation of this study is that zinc protection occurs through a mechanism independent of mitochondrial changes. Zinc pretreatment did not prevent alcohol-induced mitochondria swelling but inhibited caspases activation. This is in the line of the fact that neutralization of FasL does not decrease mitochondrial cytochrome-c release but inhibits caspase-3 activation (3) and fortifies the notion that the FasL signaling pathway plays an important role in ethanol-induced hepatic apoptosis.
Zinc is an essential trace element that plays important physiological functions as a co-factor of many Zn-requiring enzymes, in the regulation of various signal transduction pathways, and in the induction of a variety of stress proteins against toxic insults. Zinc has been shown to suppress major pathways leading to apoptosis and has direct effects on apoptosis regulators, especially caspases (5). Although this award-winning paper focused only on the role of zinc in ethanol-activated Fas/FasL pathway of apoptosis, this does not exclude the role of zinc in inhibiting other steps involved in alcohol-induced liver apoptosis. For instance, zinc preserves the integrity of the intestinal membrane and prevents alcohol-induced alterations in intestinal permeability and the subsequent release of endototoxin from the intestine into blood, thus reducing alcohol-initiated apoptotic stimuli (6). These effects of zinc on the multiple steps involved in alcohol-adverse effects would certainly make important contributions to the inhibition of alcohol-induced apoptosis.
Taken together, the work of Lambert et al. clearly demonstrated the involvement of the Fas-mediated caspase-8 and caspase-3 activation pathway in zinc-mediated protection, downstream of mitochondrial changes. This effect, together with the effects of zinc on intestinal permeability, induction of metallothionein, and the inhibition of TNF-
mediated apoptosis pathways, will play an integral role in zinc protection against alcohol-induced liver injury and would have pharmacological and clinical potential for using zinc supplementation as a therapeutic approach for alcoholic diseases.
Footnotes
We welcome comments by our readers reflecting agreement or disagreement with the material published in Experimental Biology and Medicine and, at the discretion of the Editor-in-Chief, will publish such comments. The statements and opinions contained in the articles of Experimental Biology and Medicine are solely those of the individual authors and contributors and not of the Society for Experimental Biology and Medicine.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |